Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 6,441 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 6,441 shares of Health Catalyst stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $5.43, for a total value of $34,974.63. Following the sale, the insider now directly owns 85,819 shares in the company, valued at approximately $465,997.17. The trade was a 6.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Linda Llewelyn also recently made the following trade(s):

• On Wednesday, January 15th, Linda Llewelyn sold 6,442 shares of Health Catalyst stock. The shares were sold at an average price of $5.80, for a total transaction of $37,363.60.
• On Monday, December 16th, Linda Llewelyn sold 6,442 shares of Health Catalyst stock. The shares were sold at an average price of $7.88, for a total transaction of $50,762.96.

Health Catalyst Stock Performance

Shares of Health Catalyst stock opened at $5.39 on Friday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. Health Catalyst, Inc. has a 1-year low of $5.25 and a 1-year high of $9.72. The company’s fifty day simple moving average is $6.30 and its 200-day simple moving average is $7.29.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HCAT shares. Wells Fargo & Company decreased their target price on shares of Health Catalyst from $13.00 to $10.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Canaccord Genuity Group lowered their price objective on Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a research note on Tuesday, January 21st. KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a report on Wednesday, January 8th. Stephens upped their price target on shares of Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a research note on Thursday, November 14th. Finally, Royal Bank of Canada reduced their price objective on shares of Health Catalyst from $9.00 to $7.00 and set a “sector perform” rating for the company in a research note on Wednesday, January 15th. Two equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $10.20.

Institutional Trading of Health Catalyst

Hedge funds have recently bought and sold shares of the stock. Janney Montgomery Scott LLC purchased a new position in shares of Health Catalyst during the 3rd quarter valued at about $897,000. Fred Alger Management LLC purchased a new stake in shares of Health Catalyst in the third quarter worth $6,858,000. Millrace Asset Group Inc. bought a new stake in shares of Health Catalyst during the 3rd quarter valued at $1,568,000. Point72 Asset Management L.P. boosted its holdings in Health Catalyst by 69.4% in the 3rd quarter. Point72 Asset Management L.P. now owns 516,934 shares of the company’s stock worth $4,208,000 after buying an additional 211,805 shares during the period. Finally, Impax Asset Management Group plc lifted its position in shares of Health Catalyst by 16.4% in the third quarter. Impax Asset Management Group plc now owns 2,554,475 shares of the company’s stock valued at $20,793,000 after acquiring an additional 360,201 shares in the last quarter. Institutional investors own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.